Stomach Cancer Trial, Recruiting NCT06839716 Sponsor: Gangnam Severance Hospital Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06839716
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been confirmed by laboratory testing to have a type of stomach cancer called gastric adenocarcinoma before surgery
  • People who have had surgery that completely removed the cancer with no cancer cells left at the edges (a complete removal)
  • People who have been given an anaesthesia risk score of 3 or lower by their medical team, indicating they are considered suitable for surgery
  • People aged 20 years or older
  • People who had their stomach surgery performed using laparoscopic (keyhole) or robotic techniques

Who may not be able to join:

  • People under 19 years of age
  • People who have fluid build-up in the abdomen or cancer that has spread to the lining of the abdomen
  • People who received chemotherapy or radiation treatment before their surgery
  • People who have been diagnosed with a cancer other than stomach cancer
  • People with uncontrolled diabetes, autoimmune conditions, or a history of abnormal scarring (such as raised or thickened scars) that could affect wound healing
  • People with a known allergy or past bad reaction to the local anaesthetic Ropivacaine or similar local anaesthetic medicines
  • People who are pregnant
  • People who had long-term pain conditions before surgery, including a condition called Complex Regional Pain Syndrome (CRPS) (confirm with trial site)
  • People who were regularly using strong opioid pain medicines before their surgery
  • People with mental health conditions that the medical team believes would make it difficult to take part in the study
  • People with serious liver disease, serious kidney disease, or heart rhythm problems

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 82-2-2019-4601

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Gangnam Severance Hospital
Registry
ClinicalTrials.gov
Start date
1 February 2025
Est. completion
1 February 2026

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Total fentanyl consumption within 72 hours postoperatively.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov